Dudediligence.

Scienture Holdings, Inc

SCNXNASDAQ · Pharmaceutical Preparations
Write an idea

Price
FilingsNewest: 8-K, Change to holders' rightsOct 7 →InsidersNo open-market buys or sales.→HoldersVanguard 1.2%Geode 0.8%Susquehanna International Group, LLP 0.6%→Financing →PeersClosest companies: PHGE, JSPR, SNTI→

From the filings

Figures

Revenue
$821,315last 12 months
Net income
−$38.0Mlast 12 months
Operating cash flow
−$13.3Mlast 12 months
Cash and equivalents
$8.2Mat the last balance sheet
Total debt
$2.0Mat the last balance sheet
Shares outstanding
41.1M shareson issue
Every year and quarter →